Idea Exchange Meeting with Helen Evans (GAVI Alliance CEO), Suzuki Shigeharu (Chairman of Daiwa Securities Group), and HGPI
date : 6/3/2011
Helen Evans, CEO of The Global Alliance for Vaccines and Immunizations (GAVI), along with Suzuki Shigeharu, Chairman of Daiwa Securities Group, attended a conference to discuss and exchange ideas hosted by HGPI. The GAVI Alliance works to provide vaccines for children and improve healthcare systems in developing countries; Daiwa Securities sponsors GAVI Alliance vaccine bonds to provide financial support from Japanese investors.
Although Febuarys Global Health Forum had a very broad theme, it was agreed that Japan will continue to confront global health issues using public funds and market mechanisms that use private funds. It was widely agreed that the significance of private funding needs to be expanded.
Since 2008, a total of 15 billion dollars in vaccine bonds was purchased by Japanese citizens, which supported many GAVI alliance activities. Arranged by Daiwa, vaccine bonds are issued by The International Finance Facility for Immunization Company (IFFIm). IFFIm raises funds in the international capital markets that are used by the GAVI Alliance to save children’s lives and protect people’s health by increasing access to immunization in developing countries.
Evans commenced the meeting by expression her gratitude to the Japanese for their cooperation with The GAVI Alliance. Japanese citizens have proven, and can continue to prove, the importance of their participation in innovative financial mechanisms like the vaccine bonds. In the future, GAVI Alliance, alongside Japanese businesses and think tanks, hopes to further validate the importance of strong cooperation.
Although Febuarys Global Health Forum had a very broad theme, it was agreed that Japan will continue to confront global health issues using public funds and market mechanisms that use private funds. It was widely agreed that the significance of private funding needs to be expanded.
Since 2008, a total of 15 billion dollars in vaccine bonds was purchased by Japanese citizens, which supported many GAVI alliance activities. Arranged by Daiwa, vaccine bonds are issued by The International Finance Facility for Immunization Company (IFFIm). IFFIm raises funds in the international capital markets that are used by the GAVI Alliance to save children’s lives and protect people’s health by increasing access to immunization in developing countries.
Evans commenced the meeting by expression her gratitude to the Japanese for their cooperation with The GAVI Alliance. Japanese citizens have proven, and can continue to prove, the importance of their participation in innovative financial mechanisms like the vaccine bonds. In the future, GAVI Alliance, alongside Japanese businesses and think tanks, hopes to further validate the importance of strong cooperation.
Exhibition date:2011-06-03
Top Research & Recommendations Posts
- [Policy Recommendations] Joint Statement “Protecting the Health of Both the Planet and People — A Japan-Model Planetary Health Strategy to Turn the Climate Crisis into an Opportunity for Health, the Economy, and Growth” (June 24, 2026)
- [Policy Recommendations] Toward Further Advancement of Measures Against Antimicrobial Resistance (AMR) (July 15, 2026)
- [Announcement] HGPI Joins the UHC2030 Task Force for the 2027 UN High-Level Meeting on UHC (July 6, 2026)
- [Research Report] Energy Conservation and Greenhouse Gas Emissions Reduction in Healthcare Facilities: Case Studies from New Construction and Facility Renewal (March 16, 2026)
- [Research Report] AMR Policy Update #6: The New Global Action Plan on AMR (Part 1)
- [Research Report] AMR Policy Update #7: The New Global Action Plan on AMR (Part 2)
- [Policy Recommendations] Hearing Loss Project “Recommendations on Coherent Countermeasures for Hearing Loss Throughout the Life Course: Building a Society Where Everyone Can Access Appropriate Hearing Care” (July 30, 2026)
- [Research Report] AMR Policy Update #9: Stockholm Residents’ Awareness and Practices in Returning and Recycling Pharmaceuticals: Findings from Local Interviews (July 15, 2026)
- [Policy Recommendations] Expectations for a System that Spans Diseases, Ministries, and Agencies for the Effective Promotion of Patient and Public Involvement (PPI) in Research and Development (June 30, 2026)
- [Activity Report] HGPI Contributed to the Development of the Civil 7 (C7) Global Health Working Group’s Climate and Health Thematic Brief for the G7 (June 25, 2026)
Featured Posts
-
2026-06-19
[Recommendations] Strengthening Epidemiology Education in the Veterinary Field for the One Health Era (June 19, 2026)
-
2026-07-21
[Announcement] Announcement of the 2nd Kiyoshi Kurokawa Award Recipient
-
2026-07-22
[Registration Open] Second Session of the Planetary Health Academy (Starts September 2026)
-
2026-07-31
[Policy recommendation] Reliable Policy Implementation for Early Detection and Early Intervention of Chronic Kidney Disease (CKD) (July 31, 2026)
-
2026-08-05
[Registration Open] (Webinar) The 4th J-PEP Seminar “The History of PPI in Japan and My Own PPI Journey” (September 30, 2026)



